Risk charts to identify low and excessive responders among first-cycle IVF/ICSI standard patients

被引:11
作者
Freiesleben, N. la Cour [1 ]
Gerds, T. A. [2 ]
Forman, J. L. [2 ]
Silver, J. D. [2 ]
Andersen, A. Nyboe [1 ]
Popovic-Todorovic, B. [3 ]
机构
[1] Copenhagen Univ Hosp, Rigshosp, Fertil Clin, Dept 4071, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen, Dept Biostat, DK-1014 Copenhagen K, Denmark
[3] Dutch Speaking Brussels Free Univ, Ctr Reprod Med, B-1090 Brussels, Belgium
关键词
excessive response; low response; ovarian stimulation; predictive factors; prognostic models; risk charts; ANTI-MULLERIAN HORMONE; IN-VITRO FERTILIZATION; CONTROLLED OVARIAN STIMULATION; ANTRAL FOLLICLE COUNT; HUMAN MENSTRUAL-CYCLE; RECOMBINANT FSH; PREDICTIVE FACTORS; 150; IU/DAY; IVF; PERFORMANCE;
D O I
10.1016/j.rbmo.2010.08.010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian stimulation carries a risk of either low or excessive ovarian response. The aim was to develop prognostic models for identification of standard (ovulatory and normal basal FSH) patients' risks of low and excessive response to conventional stimulation for IVF/intracytoplasmic sperm injection. Prospectively collected data on 276 first-cycle patients treated with 150 IU recombinant FSH (rFSH)/day in a long agonist protocol were analysed. Logistic regression analysis was applied to the outcome variables: low (seven or less follicles) and excessive (20 or more follicles) response. Variables were woman's age, menstrual cycle length, weight or body mass index, ovarian volume, antral follicle count (AFC) and basal FSH. The predictive performance of the models was evaluated from the prediction error (Brier score, %) where zero corresponds to a perfect prediction. Model stability was assessed using 1000 bootstrap cross-validation steps. The best prognostic model to predict low response included AFC and age (Brier score 7.94) and the best model to predict excessive response included AFC and cycle length (Brier score 15.82). Charts were developed to identify risks of low and excessive ovarian response. They can be used for evidence-based risk assessment before ovarian stimulation and may assist clinicians in individual dosage of their patients. (C) 2010, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:50 / 58
页数:9
相关论文
共 50 条
[1]   Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial [J].
Andersen, Anders Nyboe ;
Devroey, Paul ;
Arce, Joan-Carles .
HUMAN REPRODUCTION, 2006, 21 (12) :3217-3227
[2]   Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve [J].
Bancsi, LFJMM ;
Broekmans, FJM ;
Eijkemans, MJC ;
de Jong, FH ;
Habbema, JDF ;
te Velde, ER .
FERTILITY AND STERILITY, 2002, 77 (02) :328-336
[3]   Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization [J].
Brodin, Thomas ;
Bergh, Torbjorn ;
Berglund, Lars ;
Hadziosmanovic, Nermin ;
Holte, Jan .
FERTILITY AND STERILITY, 2008, 90 (05) :1656-1661
[4]   The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count [J].
Broer, Simtone L. ;
Mol, Ben Willem J. ;
Hendriks, Dave ;
Broekmans, Frank J. M. .
FERTILITY AND STERILITY, 2009, 91 (03) :705-714
[5]  
Chillik C, 2001, FERTIL STERIL, V76, P950
[6]   Improvements on cross-validation: The .632+ bootstrap method [J].
Efron, B ;
Tibshirani, R .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1997, 92 (438) :548-560
[7]   Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome [J].
Eldar-Geva, T ;
Ben-Chetrit, A ;
Spitz, IM ;
Rabinowitz, R ;
Markowitz, E ;
Mimoni, T ;
Gal, M ;
Zylber-Haran, E ;
Margalioth, EJ .
HUMAN REPRODUCTION, 2005, 20 (11) :3178-3183
[8]   Anti-Mullerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients [J].
Elgindy, Eman A. ;
El-Haieg, Dahlia O. ;
El-Sebaey, Azza .
FERTILITY AND STERILITY, 2008, 89 (06) :1670-1676
[9]   Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation [J].
Fauser, B. C. J. M. ;
Diedrich, K. ;
Devroey, P. .
HUMAN REPRODUCTION UPDATE, 2008, 14 (01) :1-14
[10]   Individual versus standard dose of rFSH in a mild stimulation protocol for intrauterine insemination: a randomized study [J].
Freiesleben, N. la Cour ;
Lossl, K. ;
Bogstad, J. ;
Bredkjaer, H. E. ;
Toft, B. ;
Rosendahl, M. ;
Loft, A. ;
Bangsboll, S. ;
Pinborg, A. ;
Andersen, A. Nyboe .
HUMAN REPRODUCTION, 2009, 24 (10) :2523-2530